Coding polymorphisms of bone morphogenetic protein 2 contribute to the development of childhood IgA nephropathy

Experimental and Therapeutic Medicine

Volumn 2, Issue 2, 2011, Pages 337-341

  Suh, Jin Soon ^a   Hahn, Won Ho ^a   Lee, Jong Seok ^a   Park, Hae Jeong ^a   Kim, Mi Ja ^a   Kang, Sung Wook ^a   Chung, Joo Ho ^a   Cho, Byoung Soo ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Bone morphogenetic protein 2; Children; Immunoglobulin a nephropathy; Polymorphism

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2;

ARTICLE; ASIAN; CHILD; CHILDHOOD; CONTROLLED STUDY; DNA POLYMORPHISM; GENE LINKAGE DISEQUILIBRIUM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUTATIONAL ANALYSIS; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79551649319     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.195     Document Type: Article

References (24)

1. Barratt J and Feehally J: IgA nephropathy. J Am Soc Nephrol 16: 2088-2097, 2005.
2. Barratt J, Smith AC, Molyneux K and Feehally J: Immunopathogenesis of IgAN. Semin Immunopathol 29: 427-443, 2007.
3. Chen D, Zhao M and Mundy GR: Bone morphogenetic proteins. Growth Factors 22: 233-241, 2004.
4. Maciel TT, Kempf H and Campos AH: Targeting bone morphogenetic protein signaling on renal and vascular diseases. Curr Opin Nephrol Hypertens 19: 26-31, 2010.
5. Simic P and Vukicevic S: Bone morphogenetic proteins in development and homeostasis of kidney. Cytokine Growth Factor Rev 16: 299-308, 2005.
6. Yang YL, Liu YS, Chuang LY, et al: Bone morphogenetic protein-2 antagonizes renal interstitial fibrosis by promoting catabolism of type I transforming growth factor-beta receptors. Endocrinology 150: 727-740, 2009.
7. Iwasaki S, Tsuruoka N, Hattori A, Sato M, Tsujimoto M and Kohno M: Distribution and characterization of specific cellular binding proteins for bone morphogenetic protein-2. J Biol Chem 270: 5476-5482, 1995.
8. Ghosh Choudhury G, Kim YS, Simon M, et al: Bone morphogenetic protein 2 inhibits platelet-derived growth factor-induced c-fos gene transcription and DNA synthesis in mesangial cells. involvement of mitogen-activated protein kinase. J Biol Chem 274: 10897-10902, 1999.
9. Ghosh Choudhury G, Jin DC, Kim Y, Celeste A, Ghosh-Choudhury N and Abboud HE: Bone morphogenetic protein-2 inhibits MAPK-dependent Elk-1 transactivation and DNA synthesis induced by EGF in mesangial cells. Biochem Biophys Res Commun 258: 490-496, 1999.
10. Pache G, Schafer C, Wiesemann S, et al: Upregulation of Id-1 via BMP-2 receptors induces reactive oxygen species in podocytes. Am J Physiol Renal Physiol 291: F654-F662, 2006.
11. Chan WL, Leung JC, Chan LY, Tam KY, Tang SC and Lai KN: BMP-7 protects mesangial cells from injury by polymeric IgA. Kidney Int 74: 1026-1039, 2008.
12. Sole X, Guino E, Valls J, Iniesta R and Moreno V: SNPStats: a web tool for the analysis of association studies. Bioinformatics 22: 1928-1929, 2006.
13. Gabriel SB, Schaffner SF, Nguyen H, et al: The structure of haplotype blocks in the human genome. Science 296: 2225-2229, 2002.
14. Nguyen TQ, Roestenberg P, van Nieuwenhoven FA, et al: CTGF inhibits BMP-7 signaling in diabetic nephropathy. J Am Soc Nephrol 19: 2098-2107, 2008.
15. Park Y, Kim JW, Kim DS, et al: The bone morphogenesis protein-2 (BMP-2) is associated with progression to metastatic disease in gastric cancer. Cancer Res Treat 40: 127-132, 2008.
16. Ara J, See J, Mamontov P, et al: Bone morphogenetic proteins 4, 6, and 7 are up-regulated in mouse spinal cord during experimental autoimmune encephalomyelitis. J Neurosci Res 86: 125-135, 2008.
17. Weiskirchen R, Meurer SK, Gressner OA, Herrmann J, Borkham-Kamphorst E and Gressner AM: BMP-7 as antagonist of organ fibrosis. Front Biosci 14: 4992-5012, 2009.
18. Rosen V: BMP2 signaling in bone development and repair. Cytokine Growth Factor Rev 20: 475-480, 2009.
19. Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P and Langenfeld J: The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis 24: 1445-1454, 2003.
20. Kleeff J, Maruyama H, Ishiwata T, et al: Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo. Gastroenterology 116: 1202-1216, 1999.
21. Liu C, Tian G, Tu Y, Fu J, Lan C and Wu N: Expression pattern and clinical prognostic relevance of bone morphogenetic protein-2 in human gliomas. Jpn J Clin Oncol 39: 625-631, 2009.
22. Baelde HJ, Eikmans M, Doran PP, Lappin DW, de Heer E and Bruijn JA: Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am J Kidney Dis 43: 636-650, 2004.
23. Dalfino G, Simone S, Porreca S, et al: Bone morphogenetic protein-2 may represent the molecular link between oxidative stress and vascular stiffness in chronic kidney disease. Atherosclerosis 211: 418-423, 2010.
24. Sieber C, Kopf J, Hiepen C and Knaus P: Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev 20: 343-355, 2009.